These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7614317)

  • 1. Managing Staphylococcus aureus catheter infection in continuous ambulatory peritoneal dialysis patients.
    Holley JL; Piraino B; Dacko C; Hayes I; Thullen A
    Adv Ren Replace Ther; 1994 Jul; 1(2):167-75. PubMed ID: 7614317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis.
    Piraino B; Bernardini J; Sorkin M
    Am J Kidney Dis; 1987 Oct; 10(4):281-6. PubMed ID: 3661549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of catheter related infections in patients on CAPD.
    Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis.
    Bayston R; Andrews M; Rigg K; Shelton A
    Perit Dial Int; 1999; 19(6):550-5. PubMed ID: 10641776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
    Ludlam HA; Young AE; Berry AJ; Phillips I
    J Hosp Infect; 1989 Nov; 14(4):293-301. PubMed ID: 2575628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritonitis associated with exit site and tunnel infections.
    Gupta B; Bernardini J; Piraino B
    Am J Kidney Dis; 1996 Sep; 28(3):415-9. PubMed ID: 8804241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
    Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis.
    Ndlovu KCZ; Swe Swe-Han K; Assounga A
    Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Ogg CS; Cameron JS; Poston S; Noble WC
    Perit Dial Int; 1989; 9(1):61-4. PubMed ID: 2488184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence of Staphylococcus aureus isolated in peritoneal dialysis-related exit-site infections to HEp-2 cells and silicone peritoneal catheter materials.
    Kreft B; Ilic S; Ziebuhr W; Kahl A; Frei U; Sack K; Trautmann M
    Nephrol Dial Transplant; 1998 Dec; 13(12):3160-4. PubMed ID: 9870482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus infections in dialysis patients: focus on prevention.
    Piraino B
    ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
    Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
    N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections.
    Herwaldt LA
    Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593
    [No Abstract]   [Full Text] [Related]  

  • 18. Peritoneal catheter exit-site and tunnel infections.
    Piraino B
    Adv Ren Replace Ther; 1996 Jul; 3(3):222-7. PubMed ID: 8827201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic shock syndrome in two CAPD patients with Staphylococcus aureus exit-site infection.
    Altiparmak MR; Demirel H; Mert A; Serdengecti K; Ataman R
    Perit Dial Int; 2003; 23(2):191-3. PubMed ID: 12713088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.